Valverde C - Search Results

1

Targeting fibroblast growth factor receptors and immune checkpoint inhibitors for the treatment of advanced bladder cancer: New direction and New Hope.

Morales-Barrera R, Suárez C, de Castro AM, Racca F, Valverde C, Maldonado X, Bastaros JM, Morote J, Carles J. Morales-Barrera R, et al. Among authors: valverde c. Cancer Treat Rev. 2016 Nov;50:208-216. doi: 10.1016/j.ctrv.2016.09.018. Epub 2016 Oct 1. Cancer Treat Rev. 2016. PMID: 27743530 Review.

2

Epidermal growth factor receptor (EGFR) inhibitors in gastrointestinal cancer.

Macarulla T, Casado E, Ramos FJ, Valverde C, Tabernero J. Macarulla T, et al. Among authors: valverde c. Onkologie. 2006 Mar;29(3):99-105. doi: 10.1159/000091013. Epub 2006 Mar 3. Onkologie. 2006. PMID: 16514271 Review.

3

Novel targets in gastric and esophageal cancer.

Valverde CM, Macarulla T, Casado E, Ramos FJ, Martinelli E, Tabernero J. Valverde CM, et al. Crit Rev Oncol Hematol. 2006 Aug;59(2):128-38. doi: 10.1016/j.critrevonc.2006.02.001. Epub 2006 Jul 10. Crit Rev Oncol Hematol. 2006. PMID: 16829119

4

Management and interpretation of novel toxicities of molecular targeted therapies: renal toxicities.

Carles J, Morales R, Perez JM, Suárez C, Rodón J, Valverde C. Carles J, et al. Among authors: valverde c. Eur J Cancer. 2009 Sep;45 Suppl 1:309-17. doi: 10.1016/S0959-8049(09)70045-0. Eur J Cancer. 2009. PMID: 19775627 Review. No abstract available.

5

Molecular basis for the treatment of renal cell carcinoma.

Suárez C, Morales R, Muñoz E, Rodón J, Valverde CM, Carles J. Suárez C, et al. Among authors: valverde cm. Clin Transl Oncol. 2010 Jan;12(1):15-21. doi: 10.1007/s12094-010-0461-4. Clin Transl Oncol. 2010. PMID: 20080466 Review.

6

Eccrine porocarcinoma presenting with scrotal lymphedema: a case report and review of systemic treatment.

Perez-Garcia J, Morales R, Valverde CM, Rodon J, Suarez C, Semidey ME, Garcia-Patos V, Bartralot R, Serra M, Carles J. Perez-Garcia J, et al. Among authors: valverde cm. Ann Oncol. 2010 Apr;21(4):907. doi: 10.1093/annonc/mdp601. Epub 2010 Jan 20. Ann Oncol. 2010. PMID: 20089564 Free article. Review. No abstract available.

7

Bilateral testicular germ cell tumours: a single hospital experience.

Morales-Barrera R, Valverde C, Rodón J, Pérez J, Maldonado X, Suárez C, Trilla E, Carles J. Morales-Barrera R, et al. Among authors: valverde c. Clin Transl Oncol. 2010 Apr;12(4):299-302. doi: 10.1007/s12094-010-0507-7. Clin Transl Oncol. 2010. PMID: 20462840

8

Emerging therapies for urothelial cancer.

Serrano C, Morales R, Suárez C, Núñez I, Valverde C, Rodón J, Humbert J, Padrós O, Carles J. Serrano C, et al. Among authors: valverde c. Cancer Treat Rev. 2012 Jun;38(4):311-7. doi: 10.1016/j.ctrv.2011.10.007. Epub 2011 Nov 22. Cancer Treat Rev. 2012. PMID: 22113129 Review.

9

Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function.

Morales-Barrera R, Bellmunt J, Suárez C, Valverde C, Guix M, Serrano C, Gallén M, Carles J. Morales-Barrera R, et al. Among authors: valverde c. Eur J Cancer. 2012 Aug;48(12):1816-21. doi: 10.1016/j.ejca.2012.04.002. Epub 2012 May 16. Eur J Cancer. 2012. PMID: 22595043 Clinical Trial.

10

BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours.

Serrano C, Simonetti S, Hernández-Losa J, Valverde C, Carrato C, Bagué S, Orellana R, Somoza R, Moliné T, Carles J, Huguet P, Romagosa C, Ramón y Cajal S. Serrano C, et al. Among authors: valverde c. Histopathology. 2013 Feb;62(3):499-504. doi: 10.1111/his.12021. Epub 2012 Nov 27. Histopathology. 2013. PMID: 23190154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page